Home page >

women health


Please find all related articles below.



Public consultation on Declaration of Helsinki on medical research involving human subjects


A two-month public consultation (15 April to 15 June 2013) on the World Medical Association’s Declaration of Helsinki on medical research involving human subjects has been launched by the World Medical Association. A revised version of the Declaration is available on the WMA website. This consultation is of particular interest in the context of the ongoing revision of the Clinical Trials legislation. Please click here for detailed information on the consultation process The (...)
25/04/2013

Health Commissioner Tonio Borg - EU Commission takes gender dimension and men’s health into account on its policies


The seminar hosted by Christel Schaldemose (S & D, DK) focused on men’s health as a vital public health issue. Health Commissioner Tonio Borg highlighted the importance of reducing health inequalities and explained how the Commission takes into account the gender dimension within its policies to improve men’s health. He stressed that prevention of diseases is much more cost effective than the cure. The résumé of the event is available here Background information On 25 (...)
20/03/2013

Women and cervical cancer in the EU


On the occasion of the European Cervical Cancer Prevention Week, the European Institute of Women’s Health (EIWH), an EPHA member, presented its policy brief "Women and cervical cancer in the EU: promoting cervical cancer prevention" emphasising the need to reach a consensus across the European Union to put an end to the existing disparities between Member States. With 31 300 women developing the disease and 13 600 dying of it every year in the EU, cervical cancer remains the second (...)
22/02/2013

Women and Cardiovascular Disease in the EU


14 February - Valentine’s Day is a good opportunity to think about women’s hearts. On its latest policy briefing, the European Institute of Women’s Health (EIWH) highlighted the key differences between women and men in matters of the heart - such as risk factors, symptoms, treatment and biomedical research. Traditionally regarded as a male disease, cardiovascular disease (CVD) is the number one killer of women worldwide. It is also a major cause of serious illness and (...)
14/02/2013

Roundtable on Clinical Trials


Hosted by the European Policy Centre (EPC), this EPC’s Coalition for Health, Ethics and Society (CHES) roundtable on the revision of the Clinical Trials legislation provided an opportunity for EPHA to present its Position on the policy dossier and exchange views with stakeholders including representatives of the European Commission, industry and an NGO representing older people. The roundtable was kicked off by Stefano Soro, Head of unit for Medicinal Products – quality, safety (...)
04/02/2013

Council conclusions on Combating Violence Against Women, and the Provision of Support Services for Victims of Domestic Violence


The Council of the European Union adopted its conclusions on Violence Against Women at its 3206th Employment, Social Policy, Health and Consumer affairs (EPSCO) Council meeting on 6 December 2012. The council calls to consider 2015 as the European Year on Zero Tolerance for Violence against Women. Considering the fact that violence against women affects society as a whole, the Council adopted a few conclusions to tackle the problem. There is NO justification whatsoever for violence (...)
18/12/2012

Revised EPHA position on clinical trials


EPHA has revised its position on clinical trials following the European Commission’s release of a legislative proposal for a regulation over the summer. While the key elements remain the same, the updated version emphasises the need for clinical trials to go ahead so that different population groups can benefit from life-saving treatments, while underlining that patient safety must remain at the centre of the process, and not compromised by less rigid assessment procedures. The (...)
29/11/2012

UN Human Rights Guidance for reduction of preventable maternal morbidity and mortality


At their 21st session, the United Nations’ Human Rights Council adopted a report aimed to help policymakers improve women’s health and rights by providing guidance on implementing policies and programmes. The Report encourages UN Members to reduce maternal mortality and morbidity in accordance with human rights standards. At their 21st session, the United Nations’ Human Rights Council adopted a report aimed to help policymakers improve women’s health and rights by (...)
04/11/2012

EPHA speaks at Gender and Health through Life conference


On June 14 and 15, EPHA spoke at the Gender and Health through Life, conference supported by the Danish Presidency of the Council of the EU. EPHA’s contribution focused on Gender and Health dimension of health promotion and disease prevention from a life course and inequalities perspectives. To mark the Danish Presidency’s EU agenda of gender, equality and healthy ageing, European Men’s Health Forum - EPHA’s member - teamed up with European Patients’ Forum, (...)
28/06/2012

New Campaign on Roma Women Empowerment launched


EPHA attended a launch of a new campaign dedicated to Roma Women Empowerment ’Our Place, Our Space, Our Case’. The aim of the campaign is to empower Roma women to gain strength and power to take control of their own lives by becoming visible agents of change within their communities and by raising their voices to influence policies and programmes affecting them. The campaign is implemented by ERGO Network together with their partner organisations from several South-Eastern (...)
22/06/2012